1. 1904PMolecular signature in malignant pleural mesothelioma (MPM): Preliminary data of Italian RAMES study. (23rd October 2018) Authors: Zanelli, F; Pagano, M; Bonelli, C; Gnoni, R; Boni, L; Ceresoli, G L; Larocca, M; Tiseo, M; Zucali, P; Grosso, F; Cappuzzo, F; Ciarrocchi, A; Torricelli, F; Pinto, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1234PCorrelation, in a real-world setting, between clinical-disease characteristics and compliance with immunotherapy in solid metastatic tumors: First results of an Italian CORE-IMMUNO study. (23rd October 2018) Authors: Masini, C; Berselli, A; Banzi, M; Bonelli, C; Romagnani, A; Pagano, M; Damato, A; Prati, G; Gasparini, E; Moretti, G; Lorenzetti, I T; Zanelli, F; Iachetta, F; Pinto, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1818TiPMulticentre, double-blind, randomised phase II study evaluating gemcitabine with or without ramucirumab as II line treatment for MPM. (23rd October 2018) Authors: Pagano, M; Zanelli, F; Gnoni, R; Bonelli, C; Tiseo, M; Boni, L; Ceresoli, G L; Zucali, P A; Grosso, F; Pasello, G; Cappuzzo, F; Pinto, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗